InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
81.97
(
0.00%
)
Bitcoin
68,703.99
(
0.25%
)
Post# of 251938
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 829
Posts 119690
Boards Moderated 16
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 188477

Thursday, 04/30/2015 9:42:53 AM

Thursday, April 30, 2015 9:42:53 AM

Post# of 251938
Re: OCRX cash guidance and clinical update

http://finance.yahoo.com/news/ocera-reports-pipeline-progress-first-120500489.html

OCRX has enrolled “more than 70” patients in STOP-HE, which means that <160 patients (of the 230 in the upsized trial) are yet to be enrolled; guidance for completion of enrollment is 2H16.

Cash at 3/31/15 was $46.1M. Guidance for 2015 cash burn is $28-32M; since $5.1 was burned during 1Q15 (#msg-111643705), the guidance implies burn for the 9-month period from 4/1/15 to 12/31/15 of about $23-27M, and a 2015 year-end cash balance of $19-23M (assuming no financing and no new sources of revenue).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up